Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.
Published August 1, 2012 · Recall initiated: June 7, 2012
Summary
FDA records drug Class III recall D-1426-2012, published August 1, 2012 and initiated June 7, 2012. Recalling firm: Fougera Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 444 bottles; Lot: Lot #: 418N, Exp 06/13. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fougera Pharmaceuticals, Inc.
- Distributor
- Nationwide.
- Lot
- Lot #: 418N, Exp 06/13
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADent's Extra Strength Toothache Gum, (benzocaine 20%), Net Wt. .035 Oz.. (1 g) box, C.S. Dent & Co., Erlanger,August 1, 2012
- FDATizanidine (Generic for: Zanaflex), 4 mg, 90 Tablets per Bottle, Rx only, , Mfg By: Dr Reddys Labs Ltd.,August 1, 2012
- FDAEden Quality Product Pasteurized Apple Juice from concentrate vitamin C added in a 46 fluid ounce can. ServiceAugust 1, 2012
- FDA21st Century Foods Soy Tempeh, packaged in 12 lb plastic bags and 8 oz containersAugust 1, 2012
- FDASarns Modular Perfusion System 9000, 100V with color screen. The Sarns Perfusion System 9000 is indicated forJuly 25, 2012
- FDASarns Modular Perfusion System 9000, 220/240V with color screen. The Sarns Perfusion System 9000 is indicatedJuly 25, 2012
Questions about this recall
Was Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0. recalled?
Yes. FDA published recall D-1426-2012 on August 1, 2012. Reported hazard: Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter